Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type (2014-2025) 1.4.2 Targeted biologic therapies 1.4.3 Novel therapies 1.5 Market by Application 1.5.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2014-2025) 1.5.2 Hospitals 1.5.3 Pharmacy Store 1.5.4 Online Pharmacy 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Immune-Mediated Inflammatory Diseases Treatment Market Size 2.2 Immune-Mediated Inflammatory Diseases Treatment Growth Trends by Regions 2.2.1 Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions (2014-2025) 2.2.2 Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Immune-Mediated Inflammatory Diseases Treatment Market Size by Manufacturers 3.1.1 Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Manufacturers (2014-2019) 3.1.2 Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio (CR5 and HHI) 3.2 Immune-Mediated Inflammatory Diseases Treatment Key Players Head office and Area Served 3.3 Key Players Immune-Mediated Inflammatory Diseases Treatment Product/Solution/Service 3.4 Date of Enter into Immune-Mediated Inflammatory Diseases Treatment Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2014-2019) 4.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2014-2019) 5 United States 5.1 United States Immune-Mediated Inflammatory Diseases Treatment Market Size (2014-2019) 5.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in United States 5.3 United States Immune-Mediated Inflammatory Diseases Treatment Market Size by Type 5.4 United States Immune-Mediated Inflammatory Diseases Treatment Market Size by Application 6 Europe 6.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size (2014-2019) 6.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in Europe 6.3 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type 6.4 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application 7 China 7.1 China Immune-Mediated Inflammatory Diseases Treatment Market Size (2014-2019) 7.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in China 7.3 China Immune-Mediated Inflammatory Diseases Treatment Market Size by Type 7.4 China Immune-Mediated Inflammatory Diseases Treatment Market Size by Application 8 Japan 8.1 Japan Immune-Mediated Inflammatory Diseases Treatment Market Size (2014-2019) 8.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in Japan 8.3 Japan Immune-Mediated Inflammatory Diseases Treatment Market Size by Type 8.4 Japan Immune-Mediated Inflammatory Diseases Treatment Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size (2014-2019) 9.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in Southeast Asia 9.3 Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size by Type 9.4 Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size by Application 10 India 10.1 India Immune-Mediated Inflammatory Diseases Treatment Market Size (2014-2019) 10.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in India 10.3 India Immune-Mediated Inflammatory Diseases Treatment Market Size by Type 10.4 India Immune-Mediated Inflammatory Diseases Treatment Market Size by Application 11 Central & South America 11.1 Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size (2014-2019) 11.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in Central & South America 11.3 Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type 11.4 Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application 12 International Players Profiles 12.1 GlaxoSmithKline 12.1.1 GlaxoSmithKline Company Details 12.1.2 Company Description and Business Overview 12.1.3 Immune-Mediated Inflammatory Diseases Treatment Introduction 12.1.4 GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019) 12.1.5 GlaxoSmithKline Recent Development 12.2 Eli Lilly 12.2.1 Eli Lilly Company Details 12.2.2 Company Description and Business Overview 12.2.3 Immune-Mediated Inflammatory Diseases Treatment Introduction 12.2.4 Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019) 12.2.5 Eli Lilly Recent Development 12.3 AstraZeneca 12.3.1 AstraZeneca Company Details 12.3.2 Company Description and Business Overview 12.3.3 Immune-Mediated Inflammatory Diseases Treatment Introduction 12.3.4 AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019) 12.3.5 AstraZeneca Recent Development 12.4 Bristol-Myers 12.4.1 Bristol-Myers Company Details 12.4.2 Company Description and Business Overview 12.4.3 Immune-Mediated Inflammatory Diseases Treatment Introduction 12.4.4 Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019) 12.4.5 Bristol-Myers Recent Development 12.5 Sanofi 12.5.1 Sanofi Company Details 12.5.2 Company Description and Business Overview 12.5.3 Immune-Mediated Inflammatory Diseases Treatment Introduction 12.5.4 Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019) 12.5.5 Sanofi Recent Development 12.6 Roche 12.6.1 Roche Company Details 12.6.2 Company Description and Business Overview 12.6.3 Immune-Mediated Inflammatory Diseases Treatment Introduction 12.6.4 Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019) 12.6.5 Roche Recent Development 12.7 Enlivex Therapeutics 12.7.1 Enlivex Therapeutics Company Details 12.7.2 Company Description and Business Overview 12.7.3 Immune-Mediated Inflammatory Diseases Treatment Introduction 12.7.4 Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019) 12.7.5 Enlivex Therapeutics Recent Development 12.8 Immune Pharmaceuticals 12.8.1 Immune Pharmaceuticals Company Details 12.8.2 Company Description and Business Overview 12.8.3 Immune-Mediated Inflammatory Diseases Treatment Introduction 12.8.4 Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019) 12.8.5 Immune Pharmaceuticals Recent Development 12.9 Tanabe Pharma 12.9.1 Tanabe Pharma Company Details 12.9.2 Company Description and Business Overview 12.9.3 Immune-Mediated Inflammatory Diseases Treatment Introduction 12.9.4 Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019) 12.9.5 Tanabe Pharma Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Immune-Mediated Inflammatory Diseases Treatment Key Market Segments Table Key Players Immune-Mediated Inflammatory Diseases Treatment Covered Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type 2014-2025 Figure Targeted biologic therapies Figures Table Key Players of Targeted biologic therapies Figure Novel therapies Figures Table Key Players of Novel therapies Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth by Application 2014-2025 (Million US$) Figure Hospitals Case Studies Figure Pharmacy Store Case Studies Figure Online Pharmacy Case Studies Figure Immune-Mediated Inflammatory Diseases Treatment Report Years Considered Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size 2014-2025 (Million US$) Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Size and Growth Rate 2014-2025 (Million US$) Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions 2014-2025 (Million US$) Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions 2014-2019 (Million US$) Table Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions 2014-2019 Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions 2014-2019 Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions 2019 Table Market Top Trends Table Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Manufacturers (2014-2019) (Million US$) Table Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Manufacturers (2014-2019) Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Manufacturers in 2018 Table Global Immune-Mediated Inflammatory Diseases Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Immune-Mediated Inflammatory Diseases Treatment Product/Solution/Service Table Date of Enter into Immune-Mediated Inflammatory Diseases Treatment Market Table Mergers & Acquisitions, Expansion Plans Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2014-2019) (Million US$) Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size Share by Type (2014-2019) Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type (2014-2019) Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2014-2019) (Million US$) Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size Share by Application (2014-2019) Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application (2014-2019) Figure Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Application in 2018 Figure United States Immune-Mediated Inflammatory Diseases Treatment Market Size 2014-2019 (Million US$) Table United States Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2018-2019) (Million US$) Table United States Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2018-2019) Table United States Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2014-2019) (Million US$) Table United States Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2014-2019) Table United States Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2014-2019) (Million US$) Table United States Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2014-2019) Figure Europe Immune-Mediated Inflammatory Diseases Treatment Market Size 2014-2019 (Million US$) Table Europe Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2018-2019) (Million US$) Table Europe Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2018-2019) Table Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2014-2019) (Million US$) Table Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2014-2019) Table Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2014-2019) (Million US$) Table Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2014-2019) Figure China Immune-Mediated Inflammatory Diseases Treatment Market Size 2014-2019 (Million US$) Table China Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2018-2019) (Million US$) Table China Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2018-2019) Table China Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2014-20189) (Million US$) Table China Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2014-2019) Table China Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2014-2019) (Million US$) Table China Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2014-2019) Figure Japan Immune-Mediated Inflammatory Diseases Treatment Market Size 2014-2019 (Million US$) Table Japan Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2018-2019) (Million US$) Table Japan Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2018-2019) Table Japan Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2014-2019) (Million US$) Table Japan Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2014-2019) Table Japan Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2014-2019) (Million US$) Table Japan Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2014-2019) Figure Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2018-2019) Table Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2014-2019) Table Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2014-2019) Figure India Immune-Mediated Inflammatory Diseases Treatment Market Size 2014-2019 (Million US$) Table India Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2018-2019) (Million US$) Table India Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2018-2019) Table India Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2014-2019) (Million US$) Table India Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2014-2019) Table India Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2014-2019) (Million US$) Table India Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2014-2019) Figure Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size 2014-2019 (Million US$) Table Central & South America Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2018-2019) (Million US$) Table Central & South America Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2018-2019) Table Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2014-2019) (Million US$) Table Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2014-2019) Table Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2014-2019) (Million US$) Table Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2014-2019) Table GlaxoSmithKline Company Details Table GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019) (Million US$) Figure GlaxoSmithKline Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019) Table GlaxoSmithKline Recent Development Table Eli Lilly Company Details Table Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)(Million US$) Figure Eli Lilly Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019) Table Eli Lilly Recent Development Table AstraZeneca Company Details Table AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)(Million US$) Figure AstraZeneca Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019) Table AstraZeneca Recent Development Table Bristol-Myers Company Details Table Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)(Million US$) Figure Bristol-Myers Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019) Table Bristol-Myers Recent Development Table Sanofi Company Details Table Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)(Million US$) Figure Sanofi Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019) Table Sanofi Recent Development Table Roche Company Details Table Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)(Million US$) Figure Roche Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019) Table Roche Recent Development Table Enlivex Therapeutics Company Details Table Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)(Million US$) Figure Enlivex Therapeutics Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019) Table Enlivex Therapeutics Recent Development Table Immune Pharmaceuticals Company Details Table Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)(Million US$) Figure Immune Pharmaceuticals Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019) Table Immune Pharmaceuticals Recent Development Table Tanabe Pharma Company Details Table Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)(Million US$) Figure Tanabe Pharma Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019) Table Tanabe Pharma Recent Development Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions (Million US$) 2019-2025 Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Size Share by Regions (2019-2025) Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Size Share by Regions in 2025 Figure United States Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast (2019-2025)(Million USD) Figure Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast (2019-2025)(Million USD) Figure China Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast (2019-2025)(Million USD) Figure Japan Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast (2019-2025)(Million USD) Figure India Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast (2019-2025)(Million USD) Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Product (2019-2025) (Million US$) Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Product (2019-2025) Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Product in 2025 Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2025) (Million US$) Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2025) Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

GlaxoSmithKline Eli Lilly AstraZeneca Bristol-Myers Sanofi Roche Enlivex Therapeutics Immune Pharmaceuticals Tanabe Pharma